China’s drug regulator clears 45 vaccine makers in sweeping, scandal-triggered inspections

Milestones :: Perspectives

China’s drug regulator clears 45 vaccine makers in sweeping, scandal-triggered inspections

by Angus Liu |
Fierce Pharma Sep 10, 2018 10:35am
When Changchun Changsheng Life Sciences’ manufacturing malpractice sparked a nationwide outcry over vaccine safety in July, the Chinese drug authority dispatched teams to inspect all other vaccine companies. Now, the results are in.
China’s recently rebranded National Medical Products Administration (NMPA) said (Chinese) on Friday it had inspected all of the other 45 vaccine makers between July 23 and Aug. 9 and found no quality or safety problems.
Among the 45 manufacturers, 38 were complying with GMP practices and other regulations, while the other seven have ceased production for more than three years and have no products currently on the market, said the agency…